Hillsdale Investment Management Inc. Eton Pharmaceuticals, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.79 Billion
- Q4 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 17,003 shares of ETON stock, worth $289,051. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,003Holding current value
$289,051% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding ETON
# of Institutions
57Shares Held
9.62MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$47.3 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$18.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$17 Million0.36% of portfolio
-
Westside Investment Management, Inc.575KShares$9.78 Million1.61% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA566KShares$9.62 Million0.15% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $430M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...